期刊
DERMATOLOGIC SURGERY
卷 41, 期 11, 页码 1201-1211出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/DSS.0000000000000485
关键词
-
资金
- Janssen Pharmaceuticals
BACKGROUNDThe 308-nm excimer laser has been approved by the Food and Drug Administration for the treatment of psoriasis and vitiligo. Its ability to treat localized areas has led to many studies determining its potential in the treatment of focal diseases with inflammation or hypopigmentation.OBJECTIVETo review the different applications of the 308-nm excimer laser for treating dermatologic conditions.METHODS AND MATERIALSAn extensive literature review was conducted by searching PubMed, MEDLINE, and ClinicalKey to find articles pertaining to dermatologic conditions treated with the 308-nm excimer laser. Articles published that contributed to new applications of the excimer laser were included, as well as initial studies utilizing the excimer laser.RESULTSThe outcomes and results were compiled for different dermatologic conditions treated with the excimer laser.CONCLUSIONThe 308-nm excimer laser has a wide range of uses for focal inflammatory and hypopigmented conditions. Treatment is generally well tolerated, with few adverse reactions. Larger studies and studies evaluating the long-term effects of the 308-nm excimer laser are needed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据